114 related articles for article (PubMed ID: 19394977)
21. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
[TBL] [Abstract][Full Text] [Related]
22. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
23. Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation.
Da Silva Morais A; Lebrun V; Abarca-Quinones J; Brichard S; Hue L; Guigas B; Viollet B; Leclercq IA
J Hepatol; 2009 Mar; 50(3):489-500. PubMed ID: 19155087
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice.
Bauche IB; Ait El Mkadem S; Rezsohazy R; Funahashi T; Maeda N; Miranda LM; Brichard SM
Biochem Biophys Res Commun; 2006 Jul; 345(4):1414-24. PubMed ID: 16729974
[TBL] [Abstract][Full Text] [Related]
25. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction.
Pettinelli P; Videla LA
J Clin Endocrinol Metab; 2011 May; 96(5):1424-30. PubMed ID: 21325464
[TBL] [Abstract][Full Text] [Related]
27. Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.
Kaneko H; Anzai T; Nagai T; Anzai A; Takahashi T; Mano Y; Morimoto K; Maekawa Y; Itoh H; Yoshikawa T; Ogawa S; Fukuda K
Cardiovasc Res; 2011 Aug; 91(3):546-55. PubMed ID: 21447704
[TBL] [Abstract][Full Text] [Related]
28. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
Endo M; Masaki T; Seike M; Yoshimatsu H
Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
[TBL] [Abstract][Full Text] [Related]
29. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
Wada T; Miyashita Y; Sasaki M; Aruga Y; Nakamura Y; Ishii Y; Sasahara M; Kanasaki K; Kitada M; Koya D; Shimano H; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1415-25. PubMed ID: 24129399
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
[TBL] [Abstract][Full Text] [Related]
31. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
Nakano T; Cheng YF; Lai CY; Hsu LW; Chang YC; Deng JY; Huang YZ; Honda H; Chen KD; Wang CC; Chiu KW; Jawan B; Eng HL; Goto S; Chen CL
J Hepatol; 2011 Aug; 55(2):415-25. PubMed ID: 21184788
[TBL] [Abstract][Full Text] [Related]
32. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
[TBL] [Abstract][Full Text] [Related]
33. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice.
Miyawaki K; Inoue H; Keshavarz P; Mizuta K; Sato A; Sakamoto Y; Moritani M; Kunika K; Tanahashi T; Itakura M
Diabetes Res Clin Pract; 2008 Oct; 82(1):33-41. PubMed ID: 18678431
[TBL] [Abstract][Full Text] [Related]
34. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression.
Barnea M; Shamay A; Stark AH; Madar Z
Obesity (Silver Spring); 2006 Dec; 14(12):2145-53. PubMed ID: 17189540
[TBL] [Abstract][Full Text] [Related]
35. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.
Imajo K; Fujita K; Yoneda M; Nozaki Y; Ogawa Y; Shinohara Y; Kato S; Mawatari H; Shibata W; Kitani H; Ikejima K; Kirikoshi H; Nakajima N; Saito S; Maeyama S; Watanabe S; Wada K; Nakajima A
Cell Metab; 2012 Jul; 16(1):44-54. PubMed ID: 22768838
[TBL] [Abstract][Full Text] [Related]
36. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.
Handa P; Maliken BD; Nelson JE; Morgan-Stevenson V; Messner DJ; Dhillon BK; Klintworth HM; Beauchamp M; Yeh MM; Elfers CT; Roth CL; Kowdley KV
Hepatology; 2014 Jul; 60(1):133-45. PubMed ID: 24464605
[TBL] [Abstract][Full Text] [Related]
37. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
Goetzman ES; Tian L; Wood PA
Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
[TBL] [Abstract][Full Text] [Related]
38. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet.
Otabe S; Yuan X; Fukutani T; Wada N; Hashinaga T; Nakayama H; Hirota N; Kojima M; Yamada K
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E210-8. PubMed ID: 17389708
[TBL] [Abstract][Full Text] [Related]
40. HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration.
Chang ML; Yeh HC; Tsou YK; Wang CJ; Cheng HY; Sung CM; Ho YP; Chen TH; Yeh CT
Obesity (Silver Spring); 2012 Jul; 20(7):1474-80. PubMed ID: 22421894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
